Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 129.97B P/E 24.04 EPS this Y 2.00% Ern Qtrly Grth -10.30%
Income 5.72B Forward P/E 12.82 EPS next Y 9.20% 50D Avg Chg -
Sales 26.32B PEG 1.88 EPS past 5Y 10.84% 200D Avg Chg 7.00%
Dividend 3.00% Price/Book 141.87 EPS next 5Y 7.07% 52W High Chg -6.00%
Recommedations 2.60 Quick Ratio 0.90 Shares Outstanding 534M 52W Low Chg 22.00%
Insider Own 0.22% ROA 9.91% Shares Float 533.12M Beta 0.59
Inst Own 81.12% ROE 111.67% Shares Shorted/Prior 20.75M/24.47M Price 243.30
Gross Margin 75.21% Profit Margin 21.75% Avg. Volume 3,313,512 Target Price 248.99
Oper. Margin 36.66% Earnings Date Aug 1 Volume 3,014,773 Change -0.87%

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

AMGN Chatroom

User Image SweepCast Posted - 06/30/22

@SweepCast Unusual Options Observed: $AMGN with our scanner on $235 PUT Expiring: 01/20/2023 worth 419K🐻 ⬅️ Option Flow Is Crucial For Retail Traders To See Trends Ahead of Time - See Profile for More Info 🏆

User Image stockilluminati Posted - 06/30/22

$AMGN https://www.stockilluminati.com/amgn/news.php - Marketplace Roundtable - Part 6 - Biotech And Healthcare

User Image Finscreener Posted - 06/30/22

1 Day performance US Markets HeatMap of large cap stocks, Healthcare sector $ABT $DHR $AMGN $CVS $NVS Learn more: https://www.finscreener.org/map/map

User Image Trade_Hub Posted - 06/29/22

$AMGN calls above 247.10 This post is originated from our Discord Posted By @macrozz

User Image stockilluminati Posted - 06/29/22

$AMGN https://www.stockilluminati.com/amgn/news.php - ReCode Therapeutics raises $120M in round co-led by Bayer, with participation from Amgen

User Image LeftyT Posted - 06/29/22

$ARWR This is where it helps to have a big pharma partner. $AMGN is running a 20,000 patient clinical trial to gather Lp(a) data on the general population of ASCVD patients. This will give them a tremendous database to establish solid P3 outcomes criteria. Great to see them step up and make this a MAJOR program in their pipe. https://clinicaltrials.gov/ct2/show/NCT05378529

User Image stockilluminati Posted - 06/29/22

$AMGN https://www.stockilluminati.com/amgn/news.php - Can-Fite stock rises 23% as psoriasis drug beats placebo but lags behind Otezla in phase 3 trial

User Image STCKPRO Posted - 06/29/22

$AMGN NEW ARTICLE : Amgen to sell Turkish unit Gensenta for $135M https://www.stck.pro/news/AMGN/30268953

User Image stockilluminati Posted - 06/29/22

$AMGN https://www.stockilluminati.com/amgn/news.php - Amgen to sell Turkish unit Gensenta for $135M

User Image manofaction Posted - 06/28/22

today's computers, smartphones, cars, data center servers & gaming consoles rely on semiconductors for both core operations & advanced capabilities. I buy AMD I’m very good at having time off. I tend to take whole years off. AMD next ER 07-26 Q1 + 100% upside AMD is about to pass Intel in desktop market share & actually seeing higher growth with its chips powering the infotainment systems in all the new Tesla Model 3, S, X, Y. daily chart 100%+ upside. shorts are covering block buys on level 2. don't be surprised if this traps shorts & has a mega squeeze towards recent highs. shorts had their fun. ready for a leg up $amgn

User Image stockilluminati Posted - 06/28/22

$AMGN https://www.stockilluminati.com/amgn/news.php - SCHD: Why It Is Poised To Disappoint

User Image STCKPRO Posted - 06/27/22

$AMGN NEW ARTICLE : Amgen's Big Bet on Copycat Drugs Is Paying Off https://www.stck.pro/news/AMGN/30166388

User Image STCKPRO Posted - 06/27/22

$AMGN NEW ARTICLE : My Top Dividend Growth Pick In Each GICS Sector https://www.stck.pro/news/AMGN/30153233

User Image optimizedvalue Posted - 06/27/22

Published some notes on Amgen Inc $AMGN stock today https://optimizedvalue.xyz/amgen-inc-amgn-stock-analysis/

User Image SweepCast Posted - 06/27/22

What Did @SweepCast Show On It's Platform Today? $AMGN Amgen Option Alert: Sep 16 $245 Puts Sweep (3) near the Bid: 49 vs 1456 OI; Earnings 8/2 After Close [est] 🐻 |🥇 Learn more and get details on ➡️ @SweepCast You Should Understand Bid vs Ask

User Image ChartMill Posted - 06/26/22

$AMGN was analyzed by 37 analysts. The buy consensus is at 70%. So analysts seem to be mildly confident about $AMGN. https://www.chartmill.com/stock/analyzer/stock/AMGN?view=analyst-ratings&utm_source=stocktwits&utm_medium=ANALYST&utm_content=AMGN&utm_campaign=social_tracking

User Image stockilluminati Posted - 06/26/22

$AMGN https://www.stockilluminati.com/amgn/news.php - Week 26 MDA Breakout Stocks - July 2022: Short-Term Picks To Give You An Edge

User Image STCKPRO Posted - 06/26/22

$AMGN NEW ARTICLE : Week 26 MDA Breakout Stocks - July 2022: Short-Term Picks To Give You An Edge https://www.stck.pro/news/AMGN/30088961

User Image macroaxis Posted - 06/25/22

New volatility landscape for Amgen( $AMGN ), Akamai… https://www.macroaxis.com/invest/stock-volatility?s=AMGN,AKAM,FFBC,GENQ,KO,PACW #canada #canadian_equities #CA

User Image SweepCast Posted - 06/25/22

@SweepCast Unusual Options Observed : $AMGN with our scanner on $245 PUT Expiring: 09/16/2022 worth 58K🐻 All of these orders were Sweeps meaning multiexchange orders that takes on all liqudity from the options markets to fill them ⬅️ Still Don't Understand? @SweepCast - See Profile for More Info 🏆

User Image tickeron Posted - 06/24/22

$AMGN was the market's top weekly gainer, with a +5.37% jump https://srnk.us/go/3781091

User Image tickeron Posted - 06/24/22

Is this good for your portfolio? $AMGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://srnk.us/go/3780911

User Image STCKPRO Posted - 06/24/22

$AMGN NEW ARTICLE : 3 Controversial Blue Chip Dividend Stocks For When Everything Goes Wrong https://www.stck.pro/news/AMGN/29995248

User Image stockilluminati Posted - 06/24/22

$AMGN https://www.stockilluminati.com/amgn/news.php - 3 Controversial Blue Chip Dividend Stocks For When Everything Goes Wrong

User Image Bernspanke Posted - 06/24/22

$SPY $wmt $AMGN $VZ $TRV Oil spiking and bonds moving higher. Countless downgrades came through this AM. More to come. 🔻🔻🔻🔻🔻🔻

User Image MarketBeat Posted - 06/24/22

Amgen's outperform rating reiterated at Oppenheimer Holdings Inc.. $290.00 PT. https://www.marketbeat.com/r/1783182 $AMGN

User Image risenhoover Posted - 06/24/22

$AMGN / Amgen files form 11-K https://fintel.io/sf/us/amgn?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Insider_Analysis Posted - 06/24/22

$AMGN In the recent reporting quarter: 17.25% of institutions made no changes to their position https://insider-analysis.com/search_whales.php?ticker=TABLE_AMGN

User Image InsiderFinance Posted - 06/24/22

Momentum Activity: $AMGN is the #1 ticker with momentum activity traded by institutions with options transaction volume 6.3x the average daily volume, a leading indicator of market movement. Market analysis and options contracts included in screenshot of dashboard from 🔥 INSIDERFINANCE.IO 🔥 (Link in profile - @InsiderFinance)

User Image SweepCast Posted - 06/24/22

@SweepCast Unusual Options Observed : $AMGN with our scanner on $235 CALL Expiring: 07/15/2022 worth 49K🐂 All of these orders were Sweeps meaning multiexchange orders that takes on all liqudity from the options markets to fill them ⬅️ Still Don't Understand? @SweepCast - See Profile for More Info 🏆

Analyst Ratings
RBC Capital Sector Perform Apr 28, 22
BMO Capital Market Perform Apr 28, 22
Piper Sandler Overweight Apr 28, 22
Morgan Stanley Equal-Weight Apr 12, 22
Barclays Equal-Weight Apr 12, 22
Morgan Stanley Equal-Weight Feb 9, 22
Wells Fargo Equal-Weight Feb 9, 22
Barclays Equal-Weight Feb 9, 22
Oppenheimer Outperform Feb 9, 22
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Williams R Sanders Director Director May 23 Sell 250.00 600 150,000 5,501 05/23/22
Graham Jonathan P EVP, Gen. Counsel &.. EVP, Gen. Counsel & Secy. May 10 Sell 241.8114 13,500 3,264,454 37,333 05/10/22
SUGAR RONALD D Director Director May 12 Option 71.64 1,000 71,640 16,927 05/12/21
SUGAR RONALD D Director Director May 12 Sell 250.59 1,000 250,590 15,927 05/12/21
Grygiel Nancy A. SVP & CCO SVP & CCO May 12 Option 162.6 2,500 406,500 14,961 05/12/21
Grygiel Nancy A. SVP & CCO SVP & CCO May 12 Sell 252.51 2,500 631,275 12,461 05/12/21
SUGAR RONALD D Director Director Apr 15 Option 71.64 1,000 71,640 16,927 04/15/21
SUGAR RONALD D Director Director Apr 15 Sell 249.98 1,000 249,980 15,927 04/15/21
SUGAR RONALD D Director Director Mar 10 Option 71.64 1,000 71,640 16,805 03/10/21
SUGAR RONALD D Director Director Mar 10 Sell 231.53 1,000 231,530 15,805 03/10/21
Bradway Robert A Chairman, CEO and Pr.. Chairman, CEO and President Feb 22 Option 54.69 73,500 4,019,715 618,380 02/22/21
REESE DAVID M EVP, Research and De.. EVP, Research and Development Feb 16 Option 54.69 2,300 125,787 42,059 02/16/21
SUGAR RONALD D Director Director Feb 10 Option 71.64 1,000 71,640 16,805 02/10/21
SUGAR RONALD D Director Director Feb 10 Sell 238.4 1,000 238,400 15,805 02/10/21
SUGAR RONALD D Director Director Jan 14 Option 71.64 1,000 71,640 16,805 01/14/21
SUGAR RONALD D Director Director Jan 14 Sell 235.99 1,000 235,990 15,805 01/14/21